Smruthi Organics Reports Strong Q1FY27 Results, Discontinues Formulations Division
Smruthi Organics Ltd 路 Outcome 路 10 Aug 2026, 5:54 pm
Smruthi Organics Reports Strong Q1FY27 Results, Discontinues Formulations Division Smruthi Organics reported strong Q1FY27 results, with Net Profit reaching Rs 287.81 lakh, a significant turnaround from a Rs 109.54 lakh loss YoY and up 169.7% QoQ. Revenue from operations grew 55.4% YoY to Rs 2,930.22 lakh. The Board approved the discontinuance of the Formulations Marketing Division on 13 May'26, which is now classified as a discontinued operation. The core Bulk Drugs and Intermediates (API) division is now the sole operating segment. Basic EPS from continuing operations stood at Rs 2.57 versus Rs (0.91) YoY.
Original exchange filing (PDF)
More announcements from Smruthi Organics Ltd
- Outcome of Board Meeting : Unaudited Financial Results for the second quarter and half year ended 30th September 2026 路 13 Nov 2026
- Financial Results for quarter and half year ended 30.09.2026 路 13 Nov 2026
- Receipt of Brazilian Good Manufacturing Practices (GMP) Certificate 路 12 Nov 2026
- Smruthi Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Prior Intimation of Board .... 路 13 Nov 2026
- Intimation regarding receipt of ANVISA Inspection Report 路 21 Oct 2026
- Approval from CG for appointment of Ms SmruthI eaga as Whoel Time Director 路 07 Oct 2026
- Scrutinisers Report and Voting Results of AGM 路 11 Aug 2026
- Outcome of 37th Annual General Meeting held today i.e 10th August 2026 路 10 Aug 2026
